Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
When beginning a GLP-1 treatment, it is important to begin on the lowest dose for that specific medication and only increase gradually to give the body time to adjust
Semaglutide at the 2.4mg weekly dose produced 13.7 percent body weight loss at 72 weeks in the STEP 1 trial
For patients with inflammatory bowel disease (Crohn's disease or ulcerative colitis), distinguishing medication-related gastrointestinal symptoms from disease flares may prove challenging and requires close clinical monitoring
Lower blood sugar levels without needing sky-high insulin production, which can help with both weight management and hormone balance
Mechanistically, GLP-1 receptor agonists may exert vascular protective effects by suppressing inflammation, limiting oxidative stress, and modulating key enzymes involved in extracellular matrix remodeling ( Matrix metalloproteinases, particularly MMP-9, together with their endogenous inhibitors (TIMPs), play central roles in extracellular matrix turnover and structural vascular remodeling ( The reduction in CRP, a recognized marker of aortic stiffness, medial degeneration, and systemic inflammation, further supports the anti-inflammatory profile associated with GLP-1RA therapy
PLEASE NOTE: The shelf life of Retatrutide is 24 months from the manufacturing date under strict storage conditions
US$ 22.92
US$ 21.87
US$ 27.95
US$ 20.00
US$ 23.87
US$ 20.15
